Literature DB >> 9934800

Correlation between Gleason score of needle biopsy and radical prostatectomy tissue.

M Cecchi1, R Minervini, C A Sepich, C Ippolito, G L Pagni, D Summonti, A Di Benedetto, L Fiorentini.   

Abstract

Gleason score has been identified as an important variable to predict disease extent and biologic behaviour of prostate cancer. However, the correlation between Gleason score of needle biopsy and surgical specimen is often poor. We studied 72 patients who underwent needle biopsy and radical prostatectomy to correlate Gleason score with PSA, clinical and pathological tumour stage. Only 47.2% of Gleason scores were identical in the biopsy and specimens, 37.5% were undergraded and 15.2% were overgraded. Correlations between clinical and pathological stage were identical in 30.5% of patients, 61.1% of patients were understaged and 8.3% overstaged. In conclusion, accuracy of clinical staging and grading of prostate cancer is low. Although the Gleason score on needle biopsy might be useful to predict the final stage and grade, correlation with surgical specimen is poor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9934800     DOI: 10.1007/bf02550548

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  10 in total

1.  Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications.

Authors:  M S Cookson; N E Fleshner; S M Soloway; W R Fair
Journal:  J Urol       Date:  1997-02       Impact factor: 7.450

2.  [Value of PSA and (pre- postoperative) Gleason in predicting the potential lymphatic involvement in patients with prostatic cancer].

Authors:  F Gómez Veiga; J Díaz Bermúdez; L Alvarez Castelo; M J Lorenzo Patiño; J Rodríguez Rivera; V Chantada Abal; E Vázquez Martul; M González Martín
Journal:  Arch Esp Urol       Date:  1997 Jan-Feb       Impact factor: 0.436

3.  The impact of prostate-specific antigen, its density and the Gleason score in the prediction of extracapsular disease in prostate carcinoma.

Authors:  A Akdaş; T Tarcan; L Türkeri; T Biren; S Küllü; Y Ilker
Journal:  Eur Urol       Date:  1997       Impact factor: 20.096

4.  Correlation of pathologic findings with progression after radical retropubic prostatectomy.

Authors:  J I Epstein; G Pizov; P C Walsh
Journal:  Cancer       Date:  1993-06-01       Impact factor: 6.860

5.  The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.

Authors:  A W Partin; J Yoo; H B Carter; J D Pearson; D W Chan; J I Epstein; P C Walsh
Journal:  J Urol       Date:  1993-07       Impact factor: 7.450

6.  Gleason grading of prostatic needle biopsies. Correlation with grade in 316 matched prostatectomies.

Authors:  D G Bostwick
Journal:  Am J Surg Pathol       Date:  1994-08       Impact factor: 6.394

7.  Effect of the number of core biopsies of the prostate on predicting Gleason score of prostate cancer.

Authors:  D Thickman; W C Speers; P J Philpott; H Shapiro
Journal:  J Urol       Date:  1996-07       Impact factor: 7.450

8.  Analysis of risk factors associated with prostate cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy.

Authors:  D A Ackerman; J M Barry; R A Wicklund; N Olson; B A Lowe
Journal:  J Urol       Date:  1993-12       Impact factor: 7.450

9.  Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens.

Authors:  P A Peller; D C Young; D P Marmaduke; W L Marsh; R A Badalament
Journal:  Cancer       Date:  1995-01-15       Impact factor: 6.860

10.  Systematic biopsies accurately predict extracapsular extension of prostate cancer and persistent/recurrent detectable PSA after radical prostatectomy.

Authors:  V Ravery; L A Boccon-Gibod; M C Dauge-Geffroy; T Billebaud; V Delmas; A Meulemans; M Toublanc; L Boccon-Gibod
Journal:  Urology       Date:  1994-09       Impact factor: 2.649

  10 in total
  1 in total

1.  Predictors of Gleason score upgrading in a large African-American population.

Authors:  Anup Vora; Tim Large; Jenny Aronica; Sherod Haynes; Andrew Harbin; Daniel Marchalik; Hanaa Nissim; John Lynch; Gaurav Bandi; Kevin McGeagh; Keith Kowalczyk; Reza Ghasemian; Krishnan Venkatesan; Mohan Verghese; Jonathan Hwang
Journal:  Int Urol Nephrol       Date:  2013-07-18       Impact factor: 2.370

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.